Groups Press F.D.A. to Approve ‘Women’s Viagra’

Sunday, May 31, 2015 - 22:10 in Health & Medicine

Flibanserin, which aims to restore lost libido in women, has been twice rejected by the F.D.A., which cited limited effectiveness as well as side effects. The drug will go before agency advisers again on Thursday.

Read the whole article on NY Times Science

More from NY Times Science

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net